Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11886004 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Conditions: Colorectal Cancer;   Appendix Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Oxaliplatin
2 Completed Isolated Liver Perfusion With Oxaliplatin
Condition: Unresectable Colorectal Liver Metastases
Intervention: Drug: Oxaliplatin

Indicates status has not been verified in more than two years